Next Article in Journal
Real-World Assessment of Recommended COVID-19 Vaccination Waiting Period after Chemotherapy
Next Article in Special Issue
SARS-CoV-2-Vaccine-Related Endocrine Disorders: An Updated Narrative Review
Previous Article in Journal
Exploring the Potential of Natural Killer Cell-Based Immunotherapy in Targeting High-Grade Serous Ovarian Carcinomas
Previous Article in Special Issue
Immunogenicity and Protective Efficacy of Psoralen-Inactivated SARS-CoV-2 Vaccine in Nonhuman Primates
 
 
Article

Article Versions Notes

Vaccines 2024, 12(6), 676; https://doi.org/10.3390/vaccines12060676
Action Date Notes Link
article xml file uploaded 18 June 2024 12:07 CEST Original file -
article xml uploaded. 18 June 2024 12:07 CEST Update https://www.mdpi.com/2076-393X/12/6/676/xml
article pdf uploaded. 18 June 2024 12:07 CEST Version of Record https://www.mdpi.com/2076-393X/12/6/676/pdf
article supplementary file uploaded. 18 June 2024 12:07 CEST - https://www.mdpi.com/2076-393X/12/6/676#supplementary
article html file updated 18 June 2024 12:08 CEST Original file https://www.mdpi.com/2076-393X/12/6/676/html
Back to TopTop